Lanean...
Circulating tumor cell count during zoledronic acid treatment in men with metastatic prostate cancer: a pilot study
PURPOSE: Recent clinical trials have demonstrated that zoledronic acid (ZOL) significantly prolongs survival in prostate cancer patients undergoing androgen deprivation therapy. This pilot study investigated the influence of ZOL on circulating tumor cell (CTC) counts in prostate cancer patients in a...
Gorde:
| Egile Nagusiak: | , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Asian Pacific Prostate Society (APPS)
2014
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4186959/ https://ncbi.nlm.nih.gov/pubmed/25325027 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12954/PI.14056 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|